[24 hour warning] These 7 stocks are reporting earnings very soon

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Protect Yourself from Biden's Dollar Destruction...]( [I’ve recorded a short 2 minute message that explains everything here. Simply click here now for all of the details.]( --------------------------------------------------------------- October 24, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Americans Now Favor Gold Over Stocks as an Investment Vehicle]( now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges. [See why investors are so impressed by this overlooked gold investment strategy.]( --------------------------------------------------------------- [Amazon]( Symbol: [AMZN]( Recent Price: $126.56 Average Analyst Price Target: $167.80 (38.57%) Market Cap: $1.28T Last Year's EPS: $0.31 Consensus EPS Forecast: $0.35 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Justin Post, analyst at Bank of America Securities, reiterates coverage on [Amazon (AMZN)]( in the Technology sector with a Buy rating and a price target of $174 (19 hours ago). [TipRanks.com]( also reports that [Amazon]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $167.80 . The target pricing ranges from a high forecast of $175 down to a low forecast of $150. [Amazon (AMZN)](’s last closing price was $126.56 which would put the average price target at 38.57% upside. Here are 3rd party ratings for [AMZN](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 38% (95 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Emerging EV Market Mover!]( Player Sets Stage for a Potentially Game-Changing Move in Lithium Exploration! [Get the Symbol Here]( --------------------------------------------------------------- [Stmicroelectronics]( Symbol: [STM]( Recent Price: $39.78 Average Analyst Price Target: $66.40 (59.63%) Market Cap: $36.14B Last Year's EPS: $1.1 Consensus EPS Forecast: $1.08 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Matt Ramsay, analyst at TD Cowen, reiterates coverage on [Stmicroelectronics (STM)]( in the Technology sector with a Buy rating and a price target of $65 (2 months ago). [TipRanks.com]( also reports that [Stmicroelectronics]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $66.40 . The target pricing ranges from a high forecast of $78 down to a low forecast of $62. [Stmicroelectronics (STM)](’s last closing price was $39.78 which would put the average price target at 59.63% upside. Here are 3rd party ratings for [STM](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 22% (54 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Bio-Rad Laboratories]( Symbol: [BIO]( Recent Price: $301.90 Average Analyst Price Target: $534.20 (77.71%) Market Cap: $9.05B Last Year's EPS: $3.34 Consensus EPS Forecast: $2.55 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Brandon Couillard, analyst at Jefferies, reiterates coverage on [Bio-Rad Laboratories (BIO)]( in the Healthcare sector with a Buy rating and a price target of $560 (5 days ago). [TipRanks.com]( also reports that [Bio-Rad Laboratories]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $534.20 . The target pricing ranges from a high forecast of $560 down to a low forecast of $511. [Bio-Rad Laboratories (BIO)](’s last closing price was $301.90 which would put the average price target at 77.71% upside. Here are 3rd party ratings for [BIO](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 42% (145 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Disturbing Truth About Biden's New Program To Seize Your Cash]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Hertz Global]( Symbol: [HTZ]( Recent Price: $10.65 Average Analyst Price Target: $19.20 (78.40%) Market Cap: $3.40B Last Year's EPS: $0.39 Consensus EPS Forecast: $0.65 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Stephanie Moore, analyst at Jefferies, reiterates coverage on [Hertz Global (HTZ)]( in the Industrials sector with a Buy rating and a price target of $15 (4 days ago). [TipRanks.com]( also reports that [Hertz Global]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $19.20 . The target pricing ranges from a high forecast of $21 down to a low forecast of $15. [Hertz Global (HTZ)](’s last closing price was $10.65 which would put the average price target at 78.40% upside. Here are 3rd party ratings for [HTZ](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 13% (218 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [NovoCure]( Symbol: [NVCR]( Recent Price: $14.07 Average Analyst Price Target: $38.00 (181.45%) Market Cap: $1.55B Last Year's EPS: -$0.5 Consensus EPS Forecast: -$0.5 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Jonathan Chang, analyst at Leerink Partners, reiterates coverage on [NovoCure (NVCR)]( in the Healthcare sector with a Buy rating (1 month ago). [TipRanks.com]( also reports that [NovoCure]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $38.00 . The target pricing ranges from a high forecast of $49 down to a low forecast of $25. [NovoCure (NVCR)](’s last closing price was $14.07 which would put the average price target at 181.45% upside. Here are 3rd party ratings for [NVCR](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 40% (101 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["The Prophet" issues a MAJOR warning..]( called the exact day that Bitcoin peaked... He predicted the exact hour marijuana stocks would begin their collapse... He even predicted the exact day the market would bottom after the COVID collapse... He's nailed so many major market moves with such accuracy that CNBC called him "The Prophet"... Now, he's issuing the boldest warning of his career... right down to the hour. He's predicting an EXTREMELY rare event is set to occur... one that hasn't happened for 15 years. Millions of Americans will be taken by surprise when this happens. But you have an opportunity to prepare yourself NOW. [Click here to reveal his message in full.]( --------------------------------------------------------------- [Pharming Group]( Symbol: [PHAR]( Recent Price: $10.20 Average Analyst Price Target: $38.50 (277.65%) Market Cap: $704.38M Last Year's EPS: -$0.17 Consensus EPS Forecast: -$0.02 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Pharming Group (PHAR)]( in the Healthcare sector with a Buy rating and a price target of $37 (2 months ago). [TipRanks.com]( also reports that [Pharming Group]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $38.50 . The target pricing ranges from a high forecast of $40 down to a low forecast of $37. [Pharming Group (PHAR)](’s last closing price was $10.20 which would put the average price target at 277.65% upside. Here are 3rd party ratings for [PHAR](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 31% (78 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Allison Transmission Holdings]( Symbol: [ALSN]( Recent Price: $56.64 Average Analyst Price Target: $60.40 (8.58%) Market Cap: $5.11B Last Year's EPS: $1.85 Consensus EPS Forecast: $1.62 Expected Earnings Date: Oct 26 2023 Recent Analyst Action: Tami Zakaria, analyst at J.P. Morgan, reiterates coverage on [Allison Transmission Holdings (ALSN)]( in the Industrials sector with a Hold rating and a price target of $70 (1 week ago). [TipRanks.com]( also reports that [Allison Transmission Holdings]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $60.40 . The target pricing ranges from a high forecast of $70 down to a low forecast of $48. [Allison Transmission Holdings (ALSN)](’s last closing price was $56.64 which would put the average price target at 8.58% upside. Here are 3rd party ratings for [ALSN](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Bottom 39% (154 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Drive Coast to Coast on a Single Charge]( brand-new battery technology could soon power EVs for 1,000 miles — on a single charge. To put that in perspective... - If you were to drive a Nissan Leaf from coast to coast, you’d have to recharge the battery eight times… - A Chevy Bolt, seven times… - Even the Tesla Model X would need to be charged six times. - And you’d have to hang around for anywhere between one and 12 hours at each charging station. - But with this new battery technology in your vehicle, you’d only have to recharge ONCE … in a matter of minutes. The company that pioneered this new technology could be the investment of a lifetime. [Watch this video for the details.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software